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After the introduction of coronary stenting, intravascular
ultrasound (IVUS) was established as the most reliable
imaging tool to guide stenting in complex lesions,
including coverage of ostial lesions, bifurcation lesions,
left main stenting, and chronic total occlusions; and is
helpful in determining the cause of stent failures, including
in-stent restenosis. These features once veriﬁed by IVUS
were critical in the reduction of stent thrombosis of
bare-metal stents (BMS) and later of drug-eluting stents
(DES). IVUS examinations have signiﬁcantly increased
our knowledge and understanding of the mechanisms of
balloon angioplasty, stent implantation, and restenosis.
Interestingly, while IVUS is the most used intravascular
imaging modality in interventional cardiology, it is
used in <20% of percutaneous coronary intervention (PCI)
procedures.
As the focus of intracoronary imaging shifted more
toward plaque characterization and endothelial coverage
post-stenting, the limitation of relatively low resolution
(100 to 150 mm) with IVUS was apparent. In contrast,
intravascular optical coherence tomography (OCT) has
emerged as an attractive new imaging modality, which
offers superior resolution (10 to 15 mm) as well as in vivo
coronary plaque morphology. Furthermore, the U.S. Food
and Drug Administration recently approved frequency
domain (FD)–OCT systems to guide stent implantation.
The latest OCT technology enables imaging of longer
coronary segments without signiﬁcant ischemia and
motion artifact and has excellent reproducibility for
consecutive pullbacks. Whether OCT is disruptive or
complementary to IVUS has not yet been fully clariﬁed.
Here we compare IVUS performance with that of OCTand review the evidence accumulated thus far on both
imaging tools.IVUS Guidance for BMS Implantation
IVUS imaging provides information on vessel morphology
and the need for vessel preparation as well as vessel, lumen,
and lesion length measurements. IVUS-guided stent place-
ment leads to better stent expansion with large post-minimal
stent areas at higher inﬂation pressures, thereby reducing
the risk of restenosis with BMS. Post-stenting IVUS also
veriﬁes apposition to the vessel wall and provides additional
information related to the presence of edge dissections, pla-
que protrusion, and the need for post-dilation or additional
stenting. Early on, the use of IVUS was helpful in identifying
the lack of stent expansion and inadequate stent apposition
to the vessel wall, leading to high rates of subacute stent
thrombosis. As a result, high pressure balloons were intro-
duced to improve stent deployment, which was associated
with signiﬁcant reduction of acute and subacute stent
thrombosis of BMS. A meta-analysis of the randomized
angiographic versus IVUS-guided BMS implantation trials
showed that IVUS reduced restenosis and repeat revascular-
ization, but not death or myocardial infarction (1).IVUS Guidance for DES Implantation
The limited data on IVUS-guided DES deployment suggests
that IVUS guidance may be important to ensure optimal
stent expansion and stent-strut apposition with DES
(Table 1), particularly in the complex PCI era of multivessel
and/or left main coronary artery stenting (2–4). The high rate
of DES thrombosis initially has led to a revived interest in
IVUS guidance for DES deployment.
As in the BMS era, stent underexpansion is a major
predictor of in-stent restenosis and subacute stent throm-
bosis in the DES era (5,6), even though the optimal minimal
stent area threshold is smaller in DESs than in BMSs (7–9).
However, whether an optimal procedural endpoint (IVUS
criteria for optimal DES deployment) exists to achieve the
best clinical outcomes after DES implantation has not been
elucidated in the randomized studies.
Table 1 IVUS Versus Angiography Guidance for DES Placement
First Author/Study
(Ref. #), Year
(Study) n Study Population Study Design
IVUS Criteria for
Optimal Expansion
Criteria
Fulﬁlled
Main Outcome
Measures Results
Roy et al. (2), 2008 1,768 De novo native
coronary lesions,
restenotic and
SVG lesions
Single-center
registry
Discretion of
the treating
operator
d Deﬁnite stent
thrombosis and
MACE at 12 months
IVUS better
(stent
thrombosis
and TLR)
Classen et al. (3),
2011 (MATRIX)
1,504
(SES)
De novo native
coronary and
restenotic lesions
Multicenter
registry
Discretion of
the treating
operator
d 30-day, 1-yr, and 2-yr
rates of death/MI,
MACE, and stent
thrombosis
IVUS better
Park et al. (4), 2009 682 Left main lesions Multicenter
registry
Discretion of the
treating operator
3-yr mortality IVUS better
Chieffo et al. (10),
2012 (AVIO)
284 De novo native
coronary lesions
Multicenter,
randomized
MSA 70% of
post-dilation
balloon calculated
according to vessel
media to media
diameters
48% Post-procedure MLD,
TLR, and MACE at
9 months; MACE
at 2 yrs
IVUS better
(post-
procedure
MLD)
PODIUM
(NCT01103765)
220 De novo native
coronary lesions
Prospective,
randomized,
multicenter
MUSIC criteria d Optimal stent deployment
deﬁned by IVUS
analysis and
complications of PCI
Ongoing
DES ¼ drug-eluting stent(s); IVUS ¼ intravascular ultrasound; MACE ¼ major adverse cardiac event(s); MI ¼ myocardial infarction; MLD ¼ minimal lumen diameter; MSA ¼ minimal stent area; MUSIC ¼
Multicenter Ultrasound Stenting in Coronaries; PCI ¼ percutaneous coronary intervention; SES ¼ sirolimus-eluting stent(s); SVG ¼ saphenous vein graft.
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of IVUS-guided optimal stent expansion with DESs
on restenosis and stent thrombosis therefore seem war-
ranted. Recently, the AVIO (Angiographic Versus IVUS
Optimization) trial demonstrated that, compared with
angiographic guidance, IVUS optimized DES implanta-
tion in complex lesions is associated with a larger post-
procedure minimal lumen diameter; however, this beneﬁt
did not lead to a signiﬁcantly lower occurrence of major
adverse cardiac events at 24 months (10). Currently, the
PODIUM (Post-dilatation for Optimization of Drug-
eluting Stents Deployment Assessed by Intravascular
Ultrasound Multicenter) study (NCT01103765) is
ongoing. The results of this trial will provide additional
important insights into the clinical signiﬁcance of IVUS-
guided stent implantation in the DES era.
OCT Guidance for Coronary Intervention
OCT provides more detailed morphological information for
monitoring stent deployment than does IVUS (11). Several
reports have shown the usefulness of OCT in complex
interventions, such as bifurcation lesions and chronic total
occlusions and in the detection of stent underexpansion
(12–14). Furthermore, it has been demonstrated that
OCT has the potential to detect stent-edge dissection (40%
vs. 16%, p ¼ 0.005), tissue protrusion (58% vs. 20%,
p < 0.001), and stent malapposition (47% vs. 8%, p <
0.001) compared with IVUS (15). However, the clinical
relevance of these small, detailed features detected by
OCT has yet to be determined. Radu et al. (16) evaluated
the relationship between procedural dissection, stentmalapposition, and delayed stent healing at 26-month
median follow-up (n ¼ 28).
Tanaka et al. (17) investigated whether OCT could predict
no-reﬂow after PCI in 83 patients with non ST-segment
elevation acute coronary syndrome. Thin-cap ﬁbroatheroma
was more frequent (50% vs. 16%, p ¼ 0.005), and the size
of the lipid arc estimated by OCT was signiﬁcantly greater
in the no-reﬂow group (166  60 vs. 44  63, p <
0.001). Final myocardial blush grade also deteriorated
according to the increase in the angle of lipid (especially
>180). A multivariable logistic regression model revealed
that lipid arc alone was an independent predictor of the
angiographic no-reﬂow (odds ratio [OR]: 1.018, 95%
conﬁdence interval [CI]: 1.004 to 1.033, p < 0.01).
Yonetsu et al. (18) used OCT to study the relationship
between pre-PCI plaque morphology and post-PCI
creatine kinase-myocardial band elevation. In the
multivariable analysis, a thin-cap ﬁbroatheroma (OR: 4.68,
95% CI: 1.88 to 11.64, p ¼ 0.001; OR: 4.20, 95% CI:
1.30 to 13.59, p ¼ 0.02) was an independent predictor of
post-PCI creatine kinase-myocardial band elevation even
in elective stent implantation. Moreover, Gonzalo et al.
(19) reported that plaque type at the stent edges, especially
lipid-rich plaque, had an impact on the presence of edge
dissections. Thus, OCT may be a useful tool for risk
stratiﬁcation of PCI.
Imola et al. (20) assessed the safety and feasibility of FD-
OCT to guide decision-making in PCI in a single-center
registry and showed that FD-OCT was a safe and feasible
tool for guidance of PCI. Furthermore, in a retrospective,
multicenter, observational study with a total of 670
patients, Prati et al. (21) reported that angiography plus
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was associated with a signiﬁcantly lower risk of cardiac
death or myocardial infarction at 1 year, even after
adjustment of important potential confounders (OR: 0.49,
95% CI: 0.25 to 0.96, p ¼ 0.037). However, further
investigations are needed to conﬁrm whether the use of
FD-OCT will improve clinical outcomes.
Comparison of IVUS and OCT Guidance
for Stent Placement
The strength of OCT lies in its ability to clearly visualize the
surface of vessel lumen, although it cannot measure plaque
burden because it requires visualization of the external elastic
membrane due to its shallow penetration depth (1 to 2 mm).
OCT can identify stent failures (e.g., stent malapposition,
dissection, tissue protrusion, and thrombus) more clearly
than IVUS. However, OCT is a novel imaging modality,
and, unlike IVUS, there are few data on the ability of OCT
to measure stent lumen area and to identify stent under-
expansion. Whether IVUS criteria for optimal stent place-
ment can be translated to OCT-guided stent implantation
remains unknown. In fact, several studies reported that
lumen dimensions measured by OCT were smaller than
those measured by IVUS (22,23). Yamaguchi et al. (22)
evaluated in vivo differences of coronary lumen dimensions
between IVUS and OCT. Minimal lumen area (MLA)
was signiﬁcantly smaller when measured by time domain-
OCT with occlusion technique versus IVUS (5.2 
2.8 mm2 vs. 5.6  2.6 mm2, p < 0.0001; mean difference,
0.4 mm2). Gonzalo et al. (23) also reported the lumen
areas measured by time domain-OCT with and without
balloon occlusion were much smaller than those measured
by IVUS (mean difference, 1.67 mm2 for an occlusion
technique and 1.11 mm2 for a nonocclusion technique).
Furthermore, Okamura et al. (24) demonstrated that MLA
measured by FD-OCT was smaller than IVUS-derived
MLA (5.84  1.89 mm2 vs. 6.26  2.01 mm2, not
signiﬁcant; mean difference, 0.42 mm2), despite the highly
signiﬁcant correlation between the 2 measurements (R2 ¼
0.82, p < 0.001). These measurement differences may lead
to suboptimal stent expansion when PCI is performed by
OCT guidance using IVUS criteria, resulting in adverse
events such as restenosis and stent thrombosis.
Unlike IVUS, currently available FD-OCT technology
for reliable image acquisition requires injection of contrast
media to displace blood from the vessel lumen because the
OCT signal is attenuated by the presence of red blood cells.
The increased contrast media volume when using FD-OCT
during PCI may impair renal function. Contrast-induced
acute kidney injury after PCI is one of major causes of in-
hospital and long-term mortality and morbidity, especially
in patients with coexisting renal dysfunction (25,26),
which limits the routine use of FD-OCT during PCI.
Hence, ﬂush medium, which substitutes for contrast, will be
necessary in the near future (27,28).It would be helpful if both systems have robust and reli-
able coregistration software to better orient the operator to
the point of interest in the vessel. This software is currently
under development and should improve the ease of analysis
both for IVUS and OCT.Conclusions and Final Thoughts
Both IVUS and OCT technologies are useful image-
guiding tools during stent implantation. Although OCT
has much higher resolution and adds more information, it is
not clear whether this additional information helps to
improve patient outcome. In contrast, additional informa-
tion may cause confusion to the operator when he or she is
instructed not to change his or her clinical judgment based
on the OCT ﬁndings. Nevertheless, it is expected that
OCT will be a useful imaging tool to guide stent implan-
tation; however, it is not yet ready for prime time. The lack
of clinical OCT data and the lack of standardized OCT
criteria for optimizing stent implantation may delay the
penetration of OCT technology despite its superior reso-
lution capabilities. Until OCT guidance can validate lumen
measurements for stent size selection and demonstrate
improvement in both early and long-term clinical outcomes
after stent implantation, it remains a useful research tool. At
present, IVUS remains the more trusted and validated
imaging modality and is our ﬁrst-choice modality to guide
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I Would Choose
Optical Coherence Tomography
Over Intravascular Ultrasound
Francesco Prati, MD,*y Mario Albertucci, MDy
There is a general consensus that optical coherence
tomography (OCT) is a breakthrough technology that
increases our understanding of the mechanism of stent
failure and provides new insights on the pathophysiology of
acute coronary syndromes (ACS) (1).
Many interventional cardiologists also agree that frequency
domain (FD)-OCT, with its marked improvement in the
acquisition process, promises to have a role in guiding
coronary interventions (PCIs) (2).
Assessment of target lesions by intravascular ultrasound
(IVUS) can be demanding. In fact, IVUS probes tend to
occlude the lumen in tight lesions, and the relatively low
1 mm/s pull-back speed may cause myocardial ischemia. Due
to the thinner proﬁle of FD-OCT probes and the faster pull-
back imaging that can reach 25 mm/s in the St. Jude Medical
system (St. Paul, Minnesota), many severely diseased target
lesions can be safely imaged without causing luminal
obstruction, thus making symptomatic ischemia much less
likely (2). As a main technical drawback, FD-OCT is not
suited to address plaques located at the very ostium of the
left or right coronary artery. Also, in the presence of very
tight stenosis, image quality can be suboptimal (2).Impact of Plaque Composition on PCI
The accurate identiﬁcation of plaque components bymeans of
OCT is a key feature to improve PCI (3). The presence, depth,
and circumferential extent of calciﬁcation can negatively
affect the results of PCI (4,5). Unlike angiography, IVUS
accurately identiﬁes calcium but is unable to measure its
thickness (6). OCT, on the other hand, can measure
superﬁcial calciﬁc components with a thickness <1.0 to
1.3 mm, affecting important decisions regarding the
operator’s strategy, such as avoidance of direct stenting and
the use of cutting balloons or rotational atherectomy.
As a relatively new concept, stent positioning should be
accomplished, aiming at complete coverage of the lipid pool
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S36(7), avoiding placement of stent edges over lipid formations,
which could lead to stent thrombosis and plaque
embolization (6). As OCT identiﬁes lipid pool with
a greater accuracy than IVUS, its pre-intervention use can
also be encouraged to reduce the risk of embolization of
plaque components.Assessment of Ambiguous Angiographic Lesions
In patients with ACS, the presence of 1 or more nonsignif-
icant lesions, exhibiting only haziness on angiography, can
pose a problem for the interventional cardiologist. In fact,
misinterpretation of culprit lesions could be the cause of
ischemic events occurring in the short- and midterm. In
angiographically hazy lesions, OCT often detects ruptured
plaques with thrombus attached to the site of the ﬁbrous
cap rupture (2,3). Under these circumstances, the decision to
proceed with treatment can stem more from morphological
observations than from the absolute measurement of lumen
area (2).
For stable patients, the decision of whether to proceed
with intervention in intermediate narrowing can be sup-
ported by an exact OCT quantiﬁcation of the minimal
lumen area. Of note, measurements obtained with OCT
tend to be slightly lower than those with IVUS (2,3). The
fact that lumen contours are easily obtained enables theFigure 1
Example of the Optical Coherence Tomography Criteria Ind
in the CLI-OPCI Study
The following deﬁnitions were applied: stent underexpansion: stent minimal lumen area (
>200 mm: intrastent tissue protrusion with a thickness >200 mm; edge dissections with a
per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary Intervention.online application of an automated algorithm that facili-
tates operator decision making by displaying the recon-
structed segment in a longitudinal view (Fig. 1) (2,4).Identiﬁcation of Vulnerable Plaques
One of the future challenges of interventional cardiology
is the characterization of vulnerable plaques. Recently,
PROSPECT (An Imaging Study in Patients With Unstable
Atherosclerotic Lesions) showed for the ﬁrst time that mild
lesions on angiography, with certain morphological IVUS
features on grayscale and virtual histology, conferred a higher
risk of cardiac events (8). OCT, due to its high accuracy in
the detection of superﬁcial plaque components, can directly
measure ﬁbrous cap thickness and lipid pool extension.
Also, the application of dedicated software promises to
identify local signs of inﬂammation. All these features
make OCT the most promising technique in identifying
plaques at risk of rupture or progression (9).
Post-Intervention Assessment
The new angle of view. The results of randomized studies
that addressed the usefulness of an IVUS-guided approach
of bare-metal stent expansion to reduce restenosis have
been disappointing (10). Only recently have the potentialicative of Nonoptimal Stent Deployment That Were Applied
MLA) >90% of mean reference lumen area; stent malapposition with a distance
width >200 mm; edge lumen narrowing with a lumen area <4 mm2. CLI-OPCI ¼ Centro
Figure 2
Incidence of the Criteria of Nonoptimal Stent
Deployment Revealed in the CLI-OPCI Study
The following deﬁnitions were applied: stent underexpansion: stent minimal lumen
area >90% mean reference lumen area; stent malapposition with a distance >200
mm; intrastent tissue protrusion with a thickness >200 mm; edge dissections with
a width >200 mm; edge lumen narrowing with a lumen area <4 mm2.
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lesions such as in the left main coronary artery. Also, IVUS
data obtained in a large propensity score–matched population
after drug-eluting stent placement showed that such an
approach may reduce the occurrence of thrombosis (11).
Consistent with this ﬁnding, the large IVUS substudy
of the ADAPT-DES (Assessment of Dual Antiplatelet
Therapy With Drug Eluting Stents) showed that the pres-
ence of attenuated plaque, tissue protrusion, reference
segment plaque burden, and edge dissection are signiﬁcant
predictors of stent thrombosis (12).
OCT represents a new angle of view as it offers higher
resolution at the expense of reduced penetration. Therefore,
IVUS-accepted criteria that require assessment of vessel
architecture, particularly measurement of the external elastic
membrane and plaque burden, cannot be obtained.
Besides enabling the comparison of the minimal stent
area with the reference area, OCT can identify details such
as stent underexpansion, malapposition, uneven stent strut
distribution, intrastent thrombotic formations, and dissec-
tions at the edges and inside the stents, with a level of
accuracy unmatched by IVUS.
Frequency of OCT ﬁndings of suboptimal stenting and
clinical role of OCT guidance. The multicenter CLI-
OPCI study (13) aimed at verifying whether the use of
OCT can improve the 1-year composite event of cardiac
death or nonfatal myocardial infarction after PCI in a real-
world population. Results from 335 patients who
underwent OCT-guided intervention were compared with
those from a control group by means of propensity score
adjustment, and the data on clinical events were very
promising indeed (Table 1).
The study addressed the burning question of how to react
to OCT ﬁndings indicative of suboptimal stent deployment
(13). Of note, OCTwas performed after achieving an optimal
angiographic result, and decisions to intervene further to
optimize stenting were made after having applied quan-
titative criteria of suboptimal positioning (Fig. 1). In 34.7%Table 1 The CLI-OPCI Study: Clinical Results
Ang
Guida
(N
In-hospital events
Cardiac death
Nonfatal MI 2
Events at 1-yr follow-up
Death 2
Cardiac death 1
MI 2
Target lesion repeat vascularization 1
Deﬁnite stent thrombosis
Cardiac death or MI 4
Cardiac death, MI, or repeat revascularization 5
Values are n (%). Data from Prati et al. (13).
CLI-OPCI ¼ Centro per la Lotta contro l’Infarto-Optimisation of Percut
optical coherence tomography.of the stented segments, it was decided, based on the OCT
results, to intervene further. This was done to improve stent
deployment, either with balloon dilation (22.3%) to correct
malapposition, underexpansion, or residual thrombus, or
with additional stenting (12.4%) to ﬁx edge dissections or
treat residual lumen narrowing (Fig. 2).
Clinical signiﬁcance of OCT ﬁndings of suboptimal
stenting. The presence of acute malapposition may be
associated with reduced re-endothelialization and neointima
formation. In patients with ACS, the occurrence of in-stent
tissue protrusion, due to presence of residual thrombus, is
a common ﬁnding. Recent data revealed that residual
intrastent thrombus is related to periprocedural myocardial
infarction in a multivariate logistic regression analysis (14).
Preliminary data from our group showed that additional
OCT-driven in-stent balloon dilation can signiﬁcantly
reduce the amount of in-stent thrombus area without
worsening the microcirculatory indexes (15).iography
nce Group
¼ 335)
Angiography Plus OCT
Guidance Group
(N ¼ 335) p Value
3 (0.9) 2 (0.6) 0.010
2 (6.5) 13 (3.9) 0.096
3 (6.9) 11 (3.3) 0.035
5 (4.5) 4 (1.2) 0.010
9 (8.7) 18 (5.4) 0.096
1 (3.3) 11 (3.3) 1.0
2 (0.6) 1 (0.3) 0.624
3 (13.0) 22 (6.6) 0.006
0 (15.1) 32 (9.6) 0.034
aneous Coronary Intervention; MI ¼myocardial infarction; OCT ¼
Table 2 Clinical Signiﬁcance of OCT Features of Nonoptimal Stent Deployment
Features
CLI-THRO (17) CLI-OPCI (13)
Subacute Thrombosis Control p Value MACE Control p Value
Underexpansion 38.1 17.4 0.12 45.4 25.9 0.079
Malapposition 52.4 37.0 0.29 31.8 30 0.815
Edge dissection 52.4 8.7 0.0003 27.3 3.8 <0.001
Reference lumen narrowing 19.0 4.3 0.07 18.2 2.9 0.007
In-stent thrombus 31.8 12.8 0.022
MACE ¼ major adverse cardiac events; OCT ¼ optical coherence tomography.
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burden >70% at the stent margin represent a risk factor for
late restenosis and thrombosis. Only the former can be ob-
tained with OCT, as plaque burden at the stent edge cannot
be measured in many circumstances due to the limits in
penetration of infrared light. Assessment of stent under-
expansion by OCT can be obtained comparing the minimal
stent area with the reference lumen area. Additionally,
a threshold of absolute minimal lumen cross-sectional area
within the stent could be applied, with an area of at least 5.0
to 5.5 mm2 previously advocated as the target minimal stent
area to prevent failure.
It is rational to assume that OCT’s potential for studying
luminal irregularities along the stent, at the edges, and in the
reference segments is a key element for the improvement of
clinical outcome and the prevention of thrombosis. This
assumption is based on the concept that lumen reduction
either in the stented segments or at the references and edge
dissections can be a more frequent cause of ﬂow impairment
than plaque dimensions per se.
Data from the OCT arm of the CLI-OPCI (16) seem to
corroborate these assumptions. Patients who experienced
major adverse cardiac events, despite the use of OCT
guidance, more often had a nonoptimal stent deployment.
Of note, for all of the OCT criteria for nonoptimal
positioning, with the exception of malapposition, dif-
ferences were highly signiﬁcant (p < 0.001). Excluding
malapposition, the percentage of patients who met at least
1 of the OCT criteria for nonoptimal stent deployment
was signiﬁcantly higher in the major adverse cardiac event
group compared with the control arm (89% vs. 39%,
p < 0.001 (Table 1).
A recent study, with a different design, provided similar
conclusions. The study addressed the incidence of subop-
timal OCT results in 21 consecutive patients exhibiting
subacute thrombosis. The patients were matched 1:2 with
a control group of 42 patients from the Rome Heart
Research core laboratory database (17). OCT showed that
minimal lumen area and minimal stent area measurements
were signiﬁcantly smaller in the stent thrombosis group
(p ¼ 0.004 and p ¼ 0.03, respectively). Furthermore, in
the group with subacute thrombosis, procedure-related
problems such as underexpansion, edge dissection, and
reference lumen narrowing were signiﬁcantly more frequent
(Table 2). In line with the CLI-OPCI conclusions,malapposition was not found to be associated with stent
thrombosis.
These preliminary ﬁndings shed light on the role of OCT
in identifying suboptimal stent positioning as an important
cause of acute or subacute stent thrombosis. These obser-
vations, consistent with the data provided by the CLI-OPCI
trial, also stressed the fact that, in the search for OCT
criteria for optimal stent positioning, there is a need to apply
explicit quantitative thresholds (Fig. 2).
Furthermore, important prospective information will be
provided by the large worldwide OCT registry set up by
I. K. Jang, with 3,000 patients scheduled for enrollment.
As a crucial application, OCT can clarify mechanisms of
restenosis and thrombosis early or late after the index
procedure, guiding repeat revascularization and thus mini-
mizing the risk of additional adverse events (15).
Conclusions
OCT is now on the stage and promises to act as a protag-
onist. There is obviously a need for more data and, in
particular, randomized studies versus coronary angiography
to better understand the role of OCT during interventional
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OCT Versus IVUS,
IVUS Versus OCT
How Is the Interventionalist to Choose?
Gary S. Mintz, MD
Drs. Waksman and Kitabata have outlined the case for
intravascular ultrasound (IVUS)–guided stent implantation,whereas Drs. Prati and Albertucci have outlined the case for
optical coherence tomography (OCT)–guided stent im-
plantation. Before addressing the pros and cons of (or
differences between) these 2 intravascular imaging tech-
niques, it is worth noting that they are more similar than
different; the major difference is not between IVUS and
OCT, but between IVUS or OCT and coronary angiog-
raphy. Both IVUS and OCT provide tomographic views of
the coronary artery and identify features of stent implantation
(e.g., expansion, inﬂow/outﬂow disease, apposition, com-
plications) as well as of mechanisms of stent failure (throm-
bosis and restenosis) that are missed using coronary
angiography alone. Therefore, the major clinical issue may
not be whether to use IVUS or OCT, but whether to use 1
of these 2 techniques to complement angiography.
That said, what are the advantages of IVUS? 1) It has
been used clinically for 2 decades. 2) Pre-intervention ima-
ging is possible in almost all patients without pre-dilation.
3) Penetration to the adventitia allows mid-wall or true
vessel stent sizing. 4) The IVUS predictors of stent failure
have been well established. 5) There are 7 randomized IVUS
versus angiography-guided bare metal stent implantation
trials, a meta-analysis of which has shown that IVUS gui-
dance reduces restenosis and repeat revascularization with no
impact on death and myocardial infarction (1). 6) There is 1
meta-analysis of 11 IVUS- versus angiography-guided drug-
eluting stent studies involving 19,616 patients showing that
IVUS guidance was associated with a reduced incidence of
death, major adverse cardiac events, and stent thrombosis
(2). This is supported by a small randomized trial from
Korea (3) as well as the pre-speciﬁed IVUS versus no-
IVUS analysis from the ADAPT-DES (Assessment of
Dual AntiPlatelet Therapy With Drug Eluting Stents)
study (4). What are the disadvantages of IVUS? 1) The
images can be difﬁcult to interpret. 2) There have been no
fundamental advances in the technology in more than
a decade. 3) Tissue characterization (especially thrombus
detection) is limited. 4) The resolution of IVUS does not
allow assessment of stent-strut tissue coverage.
Conversely, what are the advantages of OCT, especially
compared with IVUS? 1) The resolution of OCT is 10 times
greater than with IVUS such that OCT detects ﬁne details
missed by IVUS (e.g., edge dissections, small amounts of
malapposition, tissue coverage of stent struts). 2) Tissue
characterization is better, and OCT may be the gold stan-
dard for thrombus detection. 3) The images are clearer and
easier to interpret, in part because the obligatory ﬂushing
clears the lumen of blood. What are the disadvantages of
OCT? 1) Flushing is necessary to clear the lumen of blood
to visualize the vessel wall. 2) Pre-dilation may be necessary
before pre-intervention to allow static blood to be ﬂushed
from the lumen. Alternatively, some interventionalists forgo
pre-intervention imaging and only perform post-stent OCT
so that the potential advantage of pre-stent lesion assessment
and stent sizing is lost. 3) With the exception of 1 published
study cited by Prati et al. (5) stating that OCT guidance is
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on OCT predictors of stent failure, OCT criteria for stent
sizing and optimization, and the clinical beneﬁts of OCT-
guided stent implantation.
Should OCT replace IVUS? Some opinion leaders such
as Prati and Albertucci say “yes,” but the marketplace (as
indicated by Waksman and Kitabata) says “not yet.” Clinical
OCT stent studies continue to focus on: 1) detailed and
enhanced analysis of mechanisms of stent failure (restenosis
and thrombosis), especially neoatherosclerosis; 2) long-term
comparisons of different stent platforms (extent of tissue
coverage and malapposition); and 3) qualitative analysis of
the composition of neointimal tissue. Conversely, there are
few clinical studies directed at assessing the utility of the
OCT, either diagnostically or during stent-implantation
procedures. The paradigms for IVUS guidance and criteria
for IVUS optimization that have been developed over the
past 2 decades do not translate directly to OCT. Much work
needs to be done to deﬁne the best OCT-guided stent-
sizing strategy and the appropriate endpoints for OCT-
guided stent optimization.
Given the improvement in second-generation drug-eluting
stents, will it be possible to show that one technique is better
than the other?Which of the following is a better predictor of
clinical outcomes? OCT-detectable ﬁndings that are below
the resolution of IVUS?Or true vessel ormid-wall stent sizing
that increases stent expansion? Or will it always be personal
preference and the 2 techniques will coexist in an uncom-
fortable détente, each with its advocates? Finally, at the end of
the day, the question may not be IVUS or OCT, but whether
the adoption of intravascular imaging, regardless of the
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